Africa risks consuming medicines not adequately tested on Its people — Neuroscientist

Professor Mahmoud Bukar Maina, a Nigerian neuroscientist, has warned that Africans could proceed to devour medicines developed without capable investigating connected African populations, leaving patients exposed to treatments whose effects whitethorn not beryllium afloat understood successful the continent.

Maina said the occupation was not constricted to dementia research, but extended to medicine development, wherever African populations are often underrepresented successful the probe and objective investigating that find however drugs enactment and their imaginable broadside effects.

He argued, “Oftentimes, the broadside effect, you know, is due to the fact that erstwhile the cause was being developed, from the preclinical level to the objective level, it has ne'er been tested successful our ain people”

“So we are consumers, alternatively of america driving our ain needs”

He spoke successful Abuja astatine the 23rd Scientific Conference and Annual General Meeting of the Neuroscience Society of Nigeria, wherever helium called for greater concern successful probe driven by Africa’s ain wellness needs.

According to Maina, Africa’s familial diverseness makes locally generated aesculapian grounds peculiarly important, arsenic findings from studies conducted successful Europe, North America and different regions cannot ever beryllium assumed to use afloat to African populations.

He said the r...